The PE Ratio as of September 2024 (TTM) for Hoth Therapeutics, Inc. (HOTH) is -0.39

According to Hoth Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.39. This represents a change of -52.49% compared to the average of -0.82 of the last 4 quarters.

Hoth Therapeutics, Inc. (HOTH) Historical PE Ratio (quarterly & annually)

How has HOTH PE Ratio performed in the past?

The mean historical PE Ratio of Hoth Therapeutics, Inc. over the last ten years is -12.40. The current -0.39 PE Ratio has changed 214.54% with respect to the historical average. Over the past ten years (40 quarters), HOTH's PE Ratio was at its highest in in the March 2023 quarter at -0.59. The PE Ratio was at its lowest in in the December 2018 quarter at -41.87.

Hoth Therapeutics, Inc. (HOTH) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Hoth Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hoth Therapeutics, Inc. (HOTH) Average PE Ratio

How has HOTH PE Ratio performed in the past?

The current PE Ratio of Hoth Therapeutics, Inc. (HOTH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Hoth Therapeutics, Inc. (HOTH) PE Ratio vs. Peers

How is HOTH’s PE Ratio compared to its peers?

Hoth Therapeutics, Inc.’s PE Ratio is less than Avenue Therapeutics, Inc. (-0.31), less than Revelation Biosciences, Inc. (-0.09), greater than NeuroBo Pharmaceuticals, Inc. (-0.73), greater than Virax Biolabs Group Limited (-1.34), greater than Zura Bio Limited (-9.00), less than Phio Pharmaceuticals Corp. (-0.15), greater than Sonnet BioTherapeutics Holdings, Inc. (-0.55), less than 180 Life Sciences Corp. (-0.14), greater than Cardio Diagnostics Holdings, Inc. (-0.75), less than Baudax Bio, Inc. (-0.21), less than TRACON Pharmaceuticals, Inc. (0.03), less than Aditxt, Inc. (-0.02), greater than Quoin Pharmaceuticals, Ltd. (-0.47), less than Allarity Therapeutics, Inc. (-0.19), less than Kiromic BioPharma, Inc. (-0.14), less than Biodexa Pharmaceuticals Plc (-0.05), less than Blue Water Vaccines, Inc. (-0.17), less than Hillstream BioPharma, Inc. (-0.00), less than Kiora Pharmaceuticals, Inc. (4.61),

Build a custom stock screener for Hoth Therapeutics, Inc. (HOTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hoth Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hoth Therapeutics, Inc. (HOTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hoth Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.